RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
RIVANNA has announced that it received FDA 510(k) clearance for its Accuro XV Diagnostic Ultrasound System, designed for musculoskeletal imaging. The system features AI-enabled capabilities, including the BoneEnhance module for enhanced bone visualization and CADe/x for automated fracture detection. This clearance allows RIVANNA to commercialize the system for use by trained healthcare professionals and aims to improve the efficiency of imaging in emergency settings.
CHARLOTTESVILLE, Va., May 7, 2026 /PRNewswire/ — RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Accuro® XV Diagnostic Ultrasound System. The clearance marks a…